Literature DB >> 28660522

Rectal Cancer Surveillance-Recurrence Patterns and Survival Outcomes from a Cohort Followed up Beyond 10 Years.

Winson Jianhong Tan1, Hiang Jin Tan1, Sreemanee Raaj Dorajoo2, Fung Joon Foo1, Choong Leong Tang1, Min Hoe Chew3.   

Abstract

AIM: The intensity and duration of surveillance for rectal cancer after surgical resection remain contentious. We evaluated the pattern of recurrences in a rectal cancer cohort followed up beyond 10 years.
METHODS: An analysis was performed on a retrospective database of 326 patients with rectal cancer who underwent curative surgical resection from 1999 to 2007. The above study duration was chosen to ensure at least 10 years of follow-up. Data on patient demographics, peri-operative details, and follow-up outcomes were extracted from the database. The pattern of recurrences and investigative modality that detected recurrences was identified. Patients were followed up until either year 2016 or the day of their demise.
RESULTS: Two hundred seventeen patients (66.6%) were male and 109 patients (33.3%) female. Median age was 64 years old. Close to a third of the patients received adjuvant therapy (34%). Among the 326 patients studied, 29.8% of (97/326) patients developed recurrence. 7.7% (25/326) had loco-regional recurrence while 22.1% (72/326) had distant metastasis. Median time to recurrence was 16 months (4-83) and 18 months (3-81), respectively. Computed tomography scan was the best modality to detect both loco-regional and distant recurrences (48% in loco-regional and 41.7% in distant metastasis). The most common site of distant metastasis is the lung (34.7%). The salvage rate for loco-regional and distant recurrences was 52 and 12.5%, respectively.
CONCLUSION: The predominant pattern of recurrence in rectal cancer is distant disease. Surveillance regimes may need to be altered to increase early detection of distant metastases.

Entities:  

Keywords:  Investigative modality; Rectal cancer; Recurrence; Surveillance

Mesh:

Year:  2018        PMID: 28660522     DOI: 10.1007/s12029-017-9984-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  30 in total

1.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

2.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

4.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

5.  The Swedish rectal cancer registry.

Authors:  L Påhlman; M Bohe; B Cedermark; M Dahlberg; G Lindmark; R Sjödahl; B Ojerskog; L Damber; R Johansson
Journal:  Br J Surg       Date:  2007-10       Impact factor: 6.939

6.  Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer.

Authors:  Andrew G Renehan; Sarah T O'Dwyer; David K Whynes
Journal:  BMJ       Date:  2004-01-10

7.  Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model.

Authors:  Frédéric Borie; Christophe Combescure; Jean-Pierre Daurès; Brigitte Trétarre; Bertrand Millat
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

8.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

9.  Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.

Authors:  Yong Sang Hong; Byung-Ho Nam; Kyu-Pyo Kim; Jeong Eun Kim; Seong Joon Park; Young Suk Park; Joon Oh Park; Sun Young Kim; Tae-You Kim; Jee Hyun Kim; Joong Bae Ahn; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim; Seong Hyeon Yun; Jong Hoon Kim; Jin-Hong Park; Hee Chul Park; Kyung Hae Jung; Tae Won Kim
Journal:  Lancet Oncol       Date:  2014-09-04       Impact factor: 41.316

10.  Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.

Authors:  John N Primrose; Rafael Perera; Alastair Gray; Peter Rose; Alice Fuller; Andrea Corkhill; Steve George; David Mant
Journal:  JAMA       Date:  2014-01-15       Impact factor: 56.272

View more
  7 in total

Review 1.  Late-Onset Lung Metastasis in Rectum Cancer Can Be Confused with Primary Lung Cancer; a Case Report and Literature Review.

Authors:  Y Bozkaya; I Albayrak; D Tucer; Z Kaya; U Usta
Journal:  J Gastrointest Cancer       Date:  2019-12

2.  Prognostic Factors Affecting Short- and Long-Term Recurrence-Free Survival of Patients with Rectal Cancer using Cure Models: A Cohort Study.

Authors:  Seyed Vahid Hosseini; Abbas Rezaianzadeh; Salar Rahimikazerooni; Leila Ghahramani; Alimohammad Bananzadeh
Journal:  Iran J Med Sci       Date:  2020-09

3.  Changing Patterns of Distant Metastasis in Patients With Lower Rectal Cancer Undergoing Intraoperative Radiotherapy.

Authors:  Tadahiko Masaki; Hiroyoshi Matsuoka; Tomokazu Kishiki; Koichiro Kojima; Ayako Tonari; Nobuyoshi Aso; Ayumi Beniya; Aiko Iioka; Takashi Wakamatsu; Eiji Sunami
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

4.  Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients.

Authors:  Feng Zhao; Jili Wang; Hao Yu; Xiaofei Cheng; Xinke Li; Xuan Zhu; Xiangming Xu; Jianjiang Lin; Xin Chen; Senxiang Yan
Journal:  Radiat Oncol       Date:  2020-02-27       Impact factor: 3.481

Review 5.  Recurrence Risk after Radical Colorectal Cancer Surgery-Less Than before, But How High Is It?

Authors:  Erik Osterman; Klara Hammarström; Israa Imam; Emerik Osterlund; Tobias Sjöblom; Bengt Glimelius
Journal:  Cancers (Basel)       Date:  2020-11-09       Impact factor: 6.639

6.  Clinical Safety and Effectiveness of Robotic-Assisted Surgery in Patients with Rectal Cancer: Real-World Experience over 8 Years of Multiple Institutions with High-Volume Robotic-Assisted Surgery.

Authors:  Ching-Wen Huang; Po-Li Wei; Chien-Chih Chen; Li-Jen Kuo; Jaw-Yuan Wang
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

7.  Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation.

Authors:  Christina Liu Cui; William Yu Luo; Bard Clifford Cosman; Samuel Eisenstein; Daniel Simpson; Sonia Ramamoorthy; James Murphy; Nicole Lopez
Journal:  Ann Surg Oncol       Date:  2021-09-16       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.